1.Hanif R, Qiao L, Shiff SJ, Rigas B. Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. Journal of Laboratory & Clinical Medicine 1997;130(6):576-584.

2.Kune G, Kune S, Watson L. Colorectal cancer risk, chronic illnesses, operations, and medications: case-control results from the Melbourne Colorectal Cancer Study. Cancer Research 1988;48:4399-4404.

3.Tashjian AH, Jr., Voelkel EF, Goldhaber P, Levine L. Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma. Prostaglandins 1973; 3(4):515-24.

4.Pollard M, Luckert PH. Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. Cancer Treatment Reports 1980; 64(12): 1323-1327.

5.Waddell WR, Gerner RE. Indomethacin and ascorbate inhibit desmoid tumors. Journal of Surgical Oncology 1980;15(1):85-90.

6.Waddell WR. The effect of sulindac on colon polyps: circumvention of a transformed phenotype—a hypothesis. Journal of Surgical Oncology 1994;55: 52-55.

7.Waddell WR, Loughry RW. Sulindac for polyposis of the colon. Journal of Surgical Oncology 1983; 24(1):83-87.

8.Giardiello FM. NSAID-induced polyp regression in familial adenomatous polyposis patients. Gastroenterology Clinics of North America 1996;25(2):349-361.

9.Shiff SJ, Rigas B. Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology 1997;113(6):1992-8.

10.Shiff SJ, Rigas B. The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs) [comment]. J Exp Med 1999; 190 (4):445-50.

11.Rigas B, Shiff SJ. Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction. Med Hypotheses. 2000;54(2):210-5.

12.Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, et al. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 1996; 52(2):237-45.

13.Garcia-Rodriguez LA, Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 2001;12(1):88-93.

14.Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342(26):1946-52.

15.del Soldato P, Sorrentino R, Pinto A. NO-aspirins: a class of new anti-inflammatory and antithrombotic agents. Trends Pharmacol Sci 1999; 20(8):319-23.

16.Williams JL, Borgo S, Hasan I, Castillo E, Traganos F, Rigas B. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention. Cancer Res 2001; 61(8):3285-9.